Skip to main content
JUBILANT PHARMOVA LIMITED logo

JUBILANT PHARMOVA LIMITED — Investor Relations & Filings

Ticker · JUBLPHARMA ISIN · INE700A01033 LEI · 335800C6LDKWF4HQH833 BSE.NS Manufacturing
Open in API
Filings indexed 1,045 across all filing types
Latest filing 2023-08-31 AGM Information
Country IN India
Listing BSE.NS JUBLPHARMA

About JUBILANT PHARMOVA LIMITED

https://www.jubilantpharmova.com/

Jubilant Pharmova Limited is an integrated global pharmaceutical company operating through three primary segments: Pharmaceuticals, Contract Research and Development Services (CRDS), and Proprietary Novel Drugs. The Pharmaceuticals segment specializes in radiopharmaceuticals for nuclear medicine, allergy immunotherapy, and the development and manufacturing of generic formulations. It also provides Contract Development and Manufacturing Organization (CDMO) services for sterile injectables and non-sterile products. The CRDS division offers comprehensive drug discovery and development solutions to biopharmaceutical companies worldwide. Furthermore, the Proprietary Novel Drugs segment focuses on creating innovative therapies for oncology and autoimmune diseases. The company leverages its advanced manufacturing infrastructure and research capabilities to serve global markets with a focus on complex chemistry and specialized healthcare solutions.

Recent filings

Filing Released Lang Actions
Shareholders meeting
AGM Information Classification · 100% confidence The document is a detailed communication regarding the 45th Annual General Meeting (AGM) of Jubilant Pharmova Limited held on August 31, 2023. It includes the summary of proceedings, voting results, and the consolidated scrutinizer's report. The content focuses on the meeting's conduct, attendance, resolutions passed, and voting details, which are typical components of AGM information. There is no indication that this is the full annual report or financial statements, nor is it a brief announcement or a certification. The document is comprehensive and exceeds 5,000 characters, containing substantive details about the AGM itself rather than just announcing or referencing a report. Therefore, the appropriate classification is AGM Information (AGM-R).
2023-08-31 English
Shareholders meeting
Declaration of Voting Results & Voting Rights Announcements Classification · 100% confidence The document is an official communication from Jubilant Pharmova Limited to stock exchanges regarding the outcome of a postal ballot. It references Regulation 44 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, and provides detailed voting results for special resolutions related to appointments of managing directors. The content includes voting percentages, number of shares voted, and the declaration that the resolutions have been passed. This type of document is a formal announcement of voting results from a shareholder meeting or postal ballot, which fits the category of Declaration of Voting Results & Voting Rights Announcements (DVA). It is not a full report, financial statement, or management discussion, but specifically the official voting outcome announcement.
2023-08-22 English
Updates
Legal Proceedings Report Classification · 95% confidence The document is a disclosure pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, specifically about ongoing litigations of the company and its subsidiaries. It references that these litigations were already disclosed in the contingent liability schedule of the Annual Report for the Financial Year 2022-23 and states there are no material variations since then. The document is a regulatory update on legal proceedings, not a full audit or annual report, nor a detailed legal proceeding report with new case details or outcomes. It is a compliance disclosure of continuing events related to legal matters. Therefore, it fits best under Legal Proceedings Report (LTR). The document length is 4285 characters, which is not extremely short, and it contains substantive information about ongoing litigations, not just a notice or certification. Hence, it is not RNS or RPA. The classification is LTR with high confidence.
2023-08-14 English
Copy of Newspaper Publication
Notice of Dividend Amount Classification · 90% confidence The document is a letter addressed to stock exchanges (BSE and NSE) regarding the publication of newspaper advertisements communicating to shareholders about the deduction of tax at source on dividends for the financial year 2022-23. It includes details about the advertisement publication and the dividend tax deduction information. There is no detailed financial data, management discussion, or earnings information. The document is primarily an announcement related to dividend communication to shareholders, not the dividend declaration itself or a full financial report. Therefore, it fits best under the category of Notice of Dividend Amount (DIV), as it relates to dividend information communicated to shareholders.
2023-08-14 English
Copy of Newspaper Publication
AGM Information Classification · 95% confidence The document is a letter addressed to stock exchanges regarding the submission of newspaper advertisements for the 45th Annual General Meeting (AGM) and e-voting information. It mentions the dispatch of the Notice of the 45th AGM and the Annual Report for FY 2022-23, but the document itself is not the Annual Report. Instead, it is an announcement related to the AGM and the Annual Report dispatch. The document is about the AGM information and related voting procedures, not the full report or financial statements. Therefore, the appropriate classification is AGM Information (AGM-R). The document length is 15,000 characters, which is substantial, but the content is clearly an announcement and not the full report or detailed financial data.
2023-08-09 English
Shareholders meeting
AGM Information Classification · 95% confidence The document is a detailed notice regarding the 45th Annual General Meeting (AGM) of Jubilant Pharmova Limited, scheduled for August 31, 2023. It includes the AGM notice, agenda items such as adoption of audited financial statements, dividend declaration, director appointments, and auditor appointments. It also mentions the availability of the Annual Report for the financial year 2022-23 and provides instructions for electronic voting and attendance. The document is lengthy (15,000 characters) and contains the actual AGM notice and related information, not just an announcement of the report's availability. Therefore, it fits the category of AGM Information (AGM-R), as it primarily serves as the notice and materials for the Annual General Meeting rather than the Annual Report itself or a simple announcement of report publication.
2023-08-08 English

Browse filings by year

17 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.